Non-Hodgins's lymphoma (NHL) is the most common hematological malignancy worldwide,
accounting for nearly 3% of cancer diagnoses and deaths. NHL is the seventh most …

Limited comparative data exist for the treatment of HIV-associated non-Hodgkin lymphoma.
We analyzed pooled individual patient data for 1546 patients from 19 prospective clinical …

Background: The advent of highly active antiretroviral therapy (HAART) in 1996 led to a
decrease in the incidence of Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma (NHL) …

We evaluated the global patterns of non‐Hodgkin lymphoma (NHL) in 2020 using the
estimates of NHL incidence and mortality in 185 countries that are part of the GLOBOCAN …

Treatment of HIV‐infected patients with highly active antiretroviral therapy (HAART) usually
results in diminished viral replication, increasing CD4+ cell counts, a reversal of most …

Background Lymphoma is the leading cause of cancer-related death among HIV-infected
patients in the antiretroviral therapy (ART) era. Methods We studied lymphoma patients in …

Background Advancements in access to antiretroviral therapy (ART) and human
immunodeficiency virus (HIV) care have led to a decline in AIDS-related deaths among …

Cancer is the leading cause of death for HIV-infected persons in economically developed
countries, even in the era of antiretroviral therapy (ART). Lymphomas remain a leading …

The authors provide an update on the association between immune deficiency and cancer
risk in people with human immunodeficiency virus (HIV) and in solid organ transplant …

Background Research is needed to better understand relations between
immunosuppression and HIV viraemia and risk for non-Hodgkin lymphoma, a common …